cardiovascular disease

Sodium Glucose Cotransporter 2 Inhibitor and Glucagon-like Peptide 1 Receptor Agonist: New Glucose-lowering Medications and Cardiovascular Outcome

Chiang-ngernthanyakun Kittanat

PUBLISHED Jan 1, 2020 Abstract